top glp-1 companies Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Weighing in: Consumer perspectives on

Not necessarily, but they should be monitored closely by their healthcare provider

Obesity is a complex, chronic disease defined by an increase in the size and number of fat cells in the body

Osteoporosis in anorexia nervosa

In Phase 3 clinical trials completed in December 2025, retatrutide produced an average body weight reduction of 28.7% at the highest dose over 68 weeks

For patients who need modest weight loss with metabolic benefits and have access to insurance coverage, liraglutide can be a reasonable middle ground between phentermine affordability and semaglutide maximum efficacy

If you provide documentation of a valid prescription that explains the positive finding, the MRO typically reports the result as a negative (or verified) to the employer